atorvastatin has been researched along with Critical Illness in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (83.33) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Abedini, A; Amin, A; Bakhshandeh, H; Beigmohammadi, MT; Bikdeli, B; Dabbagh, A; Farrokhpour, M; Goldhaber, SZ; Gupta, A; Hadavand, N; Hajighasemi, A; Jamalkhani, S; Jimenez, D; Khalili, H; Kirtane, AJ; Krumholz, HM; Lip, GYH; Lookzadeh, S; Madhavan, MV; Maleki, M; Matin, S; Mohebbi, B; Monreal, M; Parhizgar, SE; Parikh, SA; Payandemehr, P; Piazza, G; Rashidi, F; Rezaeifar, P; Riahi, T; Sadeghian, S; Sadeghipour, P; Sezavar, H; Shahmirzaei, S; Sharif-Kashani, B; Tahamtan, O; Talasaz, AH; Yadollahzadeh, M | 1 |
| Amsterdam, EA; Armstrong, EJ; Choy, HK; Foley, TR; Kokkinidis, DG; Laird, JR; Pham, T; Rutledge, JC; Singh, GD; Waldo, SW | 1 |
| Bagshaw, SM; Bellomo, R; Cruz, DN; Gibney, N; Haase, M; Honore, PM; Joannes-Boyau, O; McAlister, FA; Palevsky, PM; Prowle, J; Ronco, C | 1 |
| Aout, M; Clarençon, F; Colonne, C; Fonfrede, M; Jean, B; Le Jean, L; Nouet, A; Puybasset, L; Sanchez-Peña, P; Vicaut, E | 1 |
| Buszman, PE; Buszman, PP; Kiesz, RS; Konkolewska, MD; Martin, JL; Radvany, MG; Szymanski, R; Wiernek, BK; Wiernek, SL | 1 |
| Bailey, M; Bellomo, R; Cooper, DJ; Harward, M; Higgins, A; Howe, B; Jones, D; Joyce, C; Kostner, K; Kruger, P; McNeil, J; Nichol, A; Roberts, MS; Syres, G; Venkatesh, B | 1 |
2 trial(s) available for atorvastatin and Critical Illness
| Article | Year |
|---|---|
Intermediate versus standard-dose prophylactic anticoagulation and statin therapy versus placebo in critically-ill patients with COVID-19: Rationale and design of the INSPIRATION/INSPIRATION-S studies.
Topics: Anticoagulants; Atorvastatin; COVID-19; COVID-19 Drug Treatment; Critical Illness; Double-Blind Method; Enoxaparin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Iran; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Thrombosis; Time Factors; Treatment Outcome; Venous Thromboembolism | 2020 |
A multicenter randomized trial of atorvastatin therapy in intensive care patients with severe sepsis.
Topics: Aged; Atorvastatin; C-Reactive Protein; Critical Illness; Double-Blind Method; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Intensive Care Units; Interleukin-6; Length of Stay; Lipids; Male; Middle Aged; Prospective Studies; Pyrroles; Sepsis | 2013 |
4 other study(ies) available for atorvastatin and Critical Illness
| Article | Year |
|---|---|
High-Intensity Statin Therapy Is Associated With Improved Survival in Patients With Peripheral Artery Disease.
Topics: Aged; Aged, 80 and over; Amputation, Surgical; Angiography; Atorvastatin; Biomarkers; Critical Illness; Disease Progression; Disease-Free Survival; Drug Prescriptions; Dyslipidemias; Endovascular Procedures; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Intermittent Claudication; Ischemia; Kaplan-Meier Estimate; Lipids; Male; Middle Aged; Peripheral Arterial Disease; Practice Patterns, Physicians'; Registries; Retrospective Studies; Risk Factors; Rosuvastatin Calcium; Time Factors; Treatment Outcome | 2017 |
Recent trials in critical care nephrology.
Topics: Acute Kidney Injury; Atorvastatin; Critical Care; Critical Illness; Decision Support Systems, Clinical; Evidence-Based Medicine; Female; Hemofiltration; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Length of Stay; Male; Metabolic Clearance Rate; Middle Aged; Multicenter Studies as Topic; Pyrroles; Random Allocation; Randomized Controlled Trials as Topic; Renal Circulation; Renal Dialysis; Renal Replacement Therapy; Sepsis; Severity of Illness Index; Survival Rate | 2010 |
Atorvastatin decreases computed tomography and S100-assessed brain ischemia after subarachnoid aneurysmal hemorrhage: a comparative study.
Topics: Adult; Aged; Atorvastatin; Biomarkers; Brain Ischemia; Case-Control Studies; Confidence Intervals; Critical Care; Critical Illness; Female; Follow-Up Studies; Glasgow Coma Scale; Heptanoic Acids; Hospitals, University; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Intensive Care Units; Male; Middle Aged; Nerve Growth Factors; Predictive Value of Tests; Pyrroles; Retrospective Studies; Risk Assessment; S100 Calcium Binding Protein beta Subunit; S100 Proteins; Severity of Illness Index; Statistics, Nonparametric; Subarachnoid Hemorrhage; Survival Rate; Tomography, X-Ray Computed; Treatment Outcome; Vasospasm, Intracranial | 2012 |
Long-term results of plaque excision combined with aggressive pharmacotherapy in high-risk patients with advanced peripheral artery disease (SAVE a LEG registry).
Topics: Adult; Aged; Aged, 80 and over; Amputation, Surgical; Aspirin; Atherectomy; Atorvastatin; Cardiovascular Agents; Clopidogrel; Combined Modality Therapy; Critical Illness; Drug Therapy, Combination; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoglycemic Agents; Intermittent Claudication; Ischemia; Kaplan-Meier Estimate; Limb Salvage; Male; Middle Aged; Peripheral Arterial Disease; Platelet Aggregation Inhibitors; Pyrroles; Recurrence; Registries; Retrospective Studies; Risk Factors; Severity of Illness Index; Ticlopidine; Time Factors; Treatment Outcome | 2013 |